Literature DB >> 23360175

Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci.

Patrick Holton1, Mina Ryten, Michael Nalls, Daniah Trabzuni, Michael E Weale, Dena Hernandez, Helen Crehan, J Raphael Gibbs, Richard Mayeux, Jonathan L Haines, Lindsay A Farrer, Margaret A Pericak-Vance, Gerard D Schellenberg, Manuel Ramirez-Restrepo, Anzhelika Engel, Amanda J Myers, Jason J Corneveaux, Matthew J Huentelman, Allissa Dillman, Mark R Cookson, Eric M Reiman, Andrew Singleton, John Hardy, Rita Guerreiro.   

Abstract

Recent genome wide association studies have identified CLU, CR1, ABCA7 BIN1, PICALM and MS4A6A/MS4A6E in addition to the long established APOE, as loci for Alzheimer's disease. We have systematically examined each of these loci to assess whether common coding variability contributes to the risk of disease. We have also assessed the regional expression of all the genes in the brain and whether there is evidence of an eQTL explaining the risk. In agreement with other studies we find that coding variability may explain the ABCA7 association, but common coding variability does not explain any of the other loci. We were not able to show that any of the loci had eQTLs within the power of this study. Furthermore the regional expression of each of the loci did not match the pattern of brain regional distribution in Alzheimer pathology. Although these results are mainly negative, they allow us to start defining more realistic alternative approaches to determine the role of all the genetic loci involved in Alzheimer's disease.
© 2013 Blackwell Publishing Ltd/University College London.

Entities:  

Mesh:

Year:  2013        PMID: 23360175      PMCID: PMC3578142          DOI: 10.1111/ahg.12000

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  68 in total

1.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Authors:  Jason J Corneveaux; Amanda J Myers; April N Allen; Jeremy J Pruzin; Manuel Ramirez; Anzhelika Engel; Michael A Nalls; Kewei Chen; Wendy Lee; Kendria Chewning; Stephen E Villa; Hunsar B Meechoovet; Jill D Gerber; Danielle Frost; Hollie L Benson; Sean O'Reilly; Lori B Chibnik; Joshua M Shulman; Andrew B Singleton; David W Craig; Kendall R Van Keuren-Jensen; Travis Dunckley; David A Bennett; Philip L De Jager; Christopher Heward; John Hardy; Eric M Reiman; Matthew J Huentelman
Journal:  Hum Mol Genet       Date:  2010-06-09       Impact factor: 6.150

2.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

Authors:  Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

3.  Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.

Authors:  V M Holers; D D Chaplin; J F Leykam; B A Gruner; V Kumar; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults.

Authors:  Meredith N Braskie; Neda Jahanshad; Jason L Stein; Marina Barysheva; Katie L McMahon; Greig I de Zubicaray; Nicholas G Martin; Margaret J Wright; John M Ringman; Arthur W Toga; Paul M Thompson
Journal:  J Neurosci       Date:  2011-05-04       Impact factor: 6.167

Review 5.  Structural and functional correlation of the human complement receptor type 1.

Authors:  W W Wong
Journal:  J Invest Dermatol       Date:  1990-06       Impact factor: 8.551

6.  Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain.

Authors:  J Raphael Gibbs; Marcel P van der Brug; Dena G Hernandez; Bryan J Traynor; Michael A Nalls; Shiao-Lin Lai; Sampath Arepalli; Allissa Dillman; Ian P Rafferty; Juan Troncoso; Robert Johnson; H Ronald Zielke; Luigi Ferrucci; Dan L Longo; Mark R Cookson; Andrew B Singleton
Journal:  PLoS Genet       Date:  2010-05-13       Impact factor: 5.917

Review 7.  Role of ATP-binding cassette transporters in brain lipid transport and neurological disease.

Authors:  Woojin Scott Kim; Cynthia Shannon Weickert; Brett Garner
Journal:  J Neurochem       Date:  2007-10-31       Impact factor: 5.372

8.  Evidence for CALM in directing VAMP2 trafficking.

Authors:  Asaff Harel; Fangbai Wu; Mark P Mattson; Christa M Morris; Pamela J Yao
Journal:  Traffic       Date:  2007-12-21       Impact factor: 6.215

9.  Alzheimer's risk variants in the clusterin gene are associated with alternative splicing.

Authors:  M Szymanski; R Wang; S S Bassett; D Avramopoulos
Journal:  Transl Psychiatry       Date:  2011       Impact factor: 6.222

10.  Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease.

Authors:  Xiaolan Hu; Eve Pickering; Yingxue Cathy Liu; Stephanie Hall; Helene Fournier; Elyse Katz; Bryan Dechairo; Sally John; Paul Van Eerdewegh; Holly Soares
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

View more
  28 in total

1.  Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.

Authors:  Jenny U Johansson; William D Brubaker; Harold Javitz; Andrew W Bergen; Denise Nishita; Abhishek Trigunaite; Andrés Crane; Justine Ceballos; Diego Mastroeni; Andrea J Tenner; Marwan Sabbagh; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2018-05-21       Impact factor: 21.566

2.  Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms.

Authors:  William D Brubaker; Andrés Crane; Jenny U Johansson; Kevin Yen; Kristina Garfinkel; Diego Mastroeni; Priya Asok; Bonnie Bradt; Marwan Sabbagh; Tanya L Wallace; Courtney Glavis-Bloom; Andrea J Tenner; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2017-05-02       Impact factor: 21.566

3.  Family-based genome scan for age at onset of late-onset Alzheimer's disease in whole exome sequencing data.

Authors:  M Saad; Z Brkanac; E M Wijsman
Journal:  Genes Brain Behav       Date:  2015-09-23       Impact factor: 3.449

4.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh
Journal:  Neuropathology       Date:  2015-01-26       Impact factor: 1.906

5.  Detection of membrane-bound and soluble antigens by magnetic levitation.

Authors:  Mikkel Schou Andersen; Emily Howard; Shulin Lu; Matthew Richard; Mark Gregory; Gordon Ogembo; Ofer Mazor; Pavel Gorelik; Nathan I Shapiro; Anish V Sharda; Ionita Ghiran
Journal:  Lab Chip       Date:  2017-10-11       Impact factor: 6.799

6.  Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology.

Authors:  Stephanie L Adams; Kathy Tilton; James A Kozubek; Sudha Seshadri; Ivana Delalle
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-26       Impact factor: 3.685

Review 7.  Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.

Authors:  Jens Pahnke; Oliver Langer; Markus Krohn
Journal:  Neurobiol Dis       Date:  2014-04-16       Impact factor: 5.996

8.  Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-β accumulation modifier.

Authors:  Takashi Morihara; Noriyuki Hayashi; Mikiko Yokokoji; Hiroyasu Akatsu; Michael A Silverman; Nobuyuki Kimura; Masahiro Sato; Yuhki Saito; Toshiharu Suzuki; Kanta Yanagida; Takashi S Kodama; Toshihisa Tanaka; Masayasu Okochi; Shinji Tagami; Hiroaki Kazui; Takashi Kudo; Ryota Hashimoto; Naohiro Itoh; Kouhei Nishitomi; Yumi Yamaguchi-Kabata; Tatsuhiko Tsunoda; Hironori Takamura; Taiichi Katayama; Ryo Kimura; Kouzin Kamino; Yoshio Hashizume; Masatoshi Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-04       Impact factor: 11.205

9.  Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells.

Authors:  Jessica E Young; Jonathan Boulanger-Weill; Daniel A Williams; Grace Woodruff; Floyd Buen; Arra C Revilla; Cheryl Herrera; Mason A Israel; Shauna H Yuan; Steven D Edland; Lawrence S B Goldstein
Journal:  Cell Stem Cell       Date:  2015-03-12       Impact factor: 25.269

10.  Multilocus genetic profiling to empower drug trials and predict brain atrophy.

Authors:  Omid Kohannim; Xue Hua; Priya Rajagopalan; Derrek P Hibar; Neda Jahanshad; Joshua D Grill; Liana G Apostolova; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage Clin       Date:  2013-06-13       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.